Agoraphobia and Driving: Fear, Avoidance, and Exposure-Based Treatment
Updated: Oct 8
Author: Ukrainian Psychological Hub · Published: October 1, 2026 · Editorial Policy
Driving can become part of agoraphobia when the feared problem is not simply the vehicle or the road, but being in a situation where escape may feel difficult or help may seem unavailable if intense anxiety, panic-like sensations, dizziness, urgent physical symptoms, or another feared event occurs. The National Institute of Mental Health explicitly includes traveling in a car among situations that may be avoided in agoraphobia, alongside being alone outside the home and being in crowded places (NIMH). Driving-related agoraphobia can therefore be clinically meaningful, but fear of driving by itself does not establish an agoraphobia diagnosis.
This distinction matters because “driving anxiety” can arise from several different patterns. One person may fear being trapped on a freeway with no easy exit; another may fear having a panic attack behind the wheel; another may fear causing a crash after a traumatic collision; another may have a focused fear of highways or driving itself; and another may be experiencing dizziness, fainting, medication effects, or another medical problem that affects driving safety. Treatment depends on the pattern that is actually present.
This article focuses on the agoraphobic pattern: how driving becomes linked to escape and help concerns, how avoidance and safety behaviors can shrink mobility, how clinicians distinguish agoraphobia from neighboring conditions, and how exposure-based treatment can be applied without turning therapy into unsafe driving.
What “agoraphobia and driving” actually means
Agoraphobia is an anxiety disorder organized around fear and avoidance of situations in which escape may feel difficult or help may seem unavailable if distressing symptoms occur. Current international descriptions also emphasize feeling trapped, helpless, or embarrassed in feared situations (WHO). It is broader than a fear of open spaces.
For driving, the clinically important question is therefore not “Does driving make me anxious?” but “What about the driving situation feels dangerous, inescapable, or difficult to manage?”
A person with driving-related agoraphobia might fear:
• being unable to leave a freeway once committed to it;
• being trapped in traffic, at a long red light, in a tunnel, or on a bridge;
• being too far from home or another “safe” place;
• having panic-like sensations while there is no immediate place to stop;
• becoming dizzy, nauseated, faint, disoriented, or urgently needing a restroom and not being able to get help;
• driving alone because no trusted person would be present if something happened;
• being in the passenger seat because leaving the situation is not under their control;
• routes with long distances between exits, parking areas, medical facilities, or familiar places.
The same person may drive comfortably on a short neighborhood route yet avoid highways, unfamiliar areas, long bridges, rush-hour traffic, or driving alone. That pattern can make sense within agoraphobia because perceived escape and access to help change across contexts.
Agoraphobia is the broader diagnostic owner in this knowledge network. This page focuses specifically on driving as one possible agoraphobic context.
Why highways, traffic, red lights, bridges, and distance can become triggers
Driving contains several features that can amplify agoraphobic threat predictions. The vehicle is moving, stopping options are constrained, road rules limit when a person can exit, and some routes create long intervals before a safe place to pull over. The driver must also continue performing a complex task while experiencing anxiety.
Older clinical research on driving fear found that highways, bridges, and tunnels were among the most commonly feared driving situations in a sample of people with driving phobia, although that study used older DSM-III-R categories and should not be treated as a modern diagnostic rule (Ehlers et al., 1994). Its continuing value is descriptive: driving fear often clusters around situations with limited perceived escape.
Highways and freeways
A freeway may feel threatening because exits are spaced apart and stopping on the roadway is unsafe. The feared prediction may be, “If I become overwhelmed now, I cannot get out.” Once avoidance begins, the person may choose surface streets even when that adds substantial time.
Traffic jams and red lights
Traffic removes the option to leave immediately. Someone who fears panic-like sensations may monitor bodily changes while also watching the line of cars ahead. A long red light can become a cue for the thought, “I am stuck until this changes.”
Bridges and tunnels
Bridges and tunnels combine constrained escape with visually salient boundaries. The person may focus on the distance to the other end, the absence of a convenient stopping point, or the possibility of becoming dizzy or panicky midway through.
Driving far from home
Distance can function as a measure of perceived safety. A person may tolerate driving within a small “safe radius” but become increasingly anxious as the route extends beyond familiar streets. Over time, that radius can contract.
Driving alone
Some people can drive when accompanied but not alone. This does not automatically mean the companion is “causing” the improvement. The companion may function as perceived help, reassurance, a potential substitute driver, or a safety signal. The classic Mobility Inventory for Agoraphobia was designed to measure avoidance separately when alone and when accompanied, reflecting the clinical importance of that distinction (Chambless et al., 1985).
Being a passenger
Agoraphobia can also affect passengers. Some people feel less anxious when someone else drives; others feel more anxious because they have less control over stopping, route choice, or leaving. The underlying fear structure matters more than whether the person occupies the driver’s seat.
Driving fear is not one diagnosis
“Fear of driving” is a symptom description, not a diagnosis. Several conditions can produce similar avoidance, and the same person can have more than one relevant condition.
Agoraphobia
Agoraphobia becomes the stronger formulation when driving is part of a broader pattern involving multiple situations where escape or help feels difficult. The person may also avoid public transportation, crowds, lines, large stores, open spaces, enclosed situations, or being outside home alone.
Agoraphobia is a distinct diagnosis. It should not be reduced to “panic disorder that has become severe.” The WHO ICD-11 Clinical Descriptions and Diagnostic Requirements classify agoraphobia separately, and panic attacks can occur in agoraphobia without establishing co-occurring panic disorder (WHO ICD-11 CDDR).
Driving phobia or a focused fear of driving
A person may have a relatively circumscribed fear centered on driving itself, particular road situations, making an error, losing control of the vehicle, or crashing. That pattern may be conceptualized clinically as a specific phobia or another driving-fear presentation, depending on the full assessment.
This distinction is particularly important for this cluster: the future article “Driving Phobia: Fear of Driving, Avoidance, and Treatment” owns the broad driving-phobia intent. The present article owns the narrower intersection between agoraphobia and driving.
Panic attacks while driving
A panic attack is an acute episode of intense fear or discomfort with physical and cognitive symptoms. A panic attack can occur in many disorders and can occur without any mental disorder. Panic disorder requires its own diagnostic pattern and is not interchangeable with agoraphobia.
If the central problem is recurrent panic attacks while driving and fear of their recurrence, see Panic Attacks While Driving. If the person also has recurrent unexpected panic attacks plus persistent concern or maladaptive behavior change afterward, Panic Disorder may be relevant to clinical assessment.
Post-traumatic stress after a crash
After a serious collision, driving may evoke intrusive memories, trauma reminders, hyperarousal, or avoidance. That pattern can point toward a trauma-related condition rather than agoraphobia, although both can coexist. A crash history should therefore be assessed rather than assumed to be the cause of every driving fear.
Social-evaluative fear
Some people primarily fear honking, criticism from passengers, making mistakes in public, being watched, or appearing incompetent. Social anxiety may be more central when negative evaluation is the feared consequence.
Medical, neurological, vestibular, and medication-related causes
Driving avoidance should not be automatically attributed to anxiety when symptoms could impair consciousness, vision, balance, attention, reaction time, or motor control.
Dizziness and vestibular disorders, for example, can affect perceived driving ability, although the evidence is heterogeneous and does not support a simple causal rule (Uwents et al., 2022). New fainting, loss of consciousness, severe or unusual dizziness, seizure-like events, focal neurological symptoms, significant visual disturbance, or concerning cardiac symptoms require medical evaluation rather than exposure exercises based on an assumption that the symptoms are “just anxiety.”
Medication effects also matter. The U.S. Food and Drug Administration notes that some prescription and over-the-counter medicines can cause drowsiness, blurred vision, dizziness, slowed or uncoordinated movement, fainting, or impaired attention, and lists benzodiazepines and some antidepressants among medications that may affect driving (FDA). The National Highway Traffic Safety Administration likewise advises against driving when a medication or other substance is impairing driving ability (NHTSA).
The avoidance cycle
Avoidance often produces immediate relief. That relief is one reason the pattern can become self-reinforcing.
A typical sequence may look like this:
1. A person experiences severe anxiety, panic-like sensations, dizziness, or a frightening thought while driving.
2. A route, road type, distance, or situation becomes associated with danger.
3. The person begins avoiding the most difficult situations.
4. Short-term anxiety decreases because the feared situation is no longer encountered.
5. Opportunities to learn that anxiety can be tolerated, that feared outcomes may not occur, or that the person can cope become less frequent.
6. The “safe” driving zone becomes narrower.
The contraction can happen gradually. First the person stops using one freeway. Then all freeways. Then bridges. Then unfamiliar routes. Then driving alone. Eventually another person may need to drive them even for short trips.
This process is clinically important because functional impairment may become greater than the intensity of anxiety during any single drive. A person can look “fine” on the routes they still use while organizing daily life around increasingly elaborate restrictions.
Avoidance versus sensible driving decisions
Not every decision to avoid a route is an anxiety symptom.
Choosing not to drive because of severe weather, fatigue, intoxication, medication impairment, an unsafe vehicle, inadequate driving skill, a medical episode, a legal restriction, or genuinely hazardous road conditions is a safety decision. Exposure therapy does not override road safety.
Likewise, a competent driver who decides not to take an unfamiliar mountain road at night is not demonstrating psychopathology merely because the route feels uncomfortable.
Clinical avoidance is better understood by its function and pattern: repeated restriction driven by feared internal experiences or catastrophic predictions, disproportionate to the actual context, that interferes with mobility or daily life.
Safety behaviors while driving
A safety behavior is an action used mainly to prevent, escape, or reduce a feared catastrophe. In driving-related agoraphobia, examples can include:
• driving only with a trusted companion;
• staying within a small radius of home;
• choosing routes with many exits;
• refusing the left lane because it feels harder to escape;
• repeatedly checking maps for hospitals, restrooms, or pull-off areas;
• carrying “rescue” items primarily as reassurance;
• constantly monitoring heart rate, breathing, dizziness, or vision;
• asking a passenger for repeated reassurance;
• keeping a second driver available “just in case”;
• driving only at unusually quiet times despite major inconvenience.
The label should be applied carefully. A seat belt is not an anxiety safety behavior; it is ordinary road safety. Checking a route once before a trip may be sensible planning. Having a qualified instructor in the vehicle when relearning driving skills is a legitimate safety measure. The same action can serve different functions in different people.
The research on deliberately removing safety-seeking behaviors during exposure is more nuanced than the slogan “drop all safety behaviors.” A meta-analytic review found the evidence inconclusive and only limited support for the claim that eliminating safety behaviors necessarily improves fear reduction (Meulders et al., 2016). Good treatment therefore examines what the behavior is doing, whether it blocks learning, and whether it is genuinely needed for safe driving.
How clinicians assess driving-related agoraphobia
There is no single online question that can determine whether fear of driving is agoraphobia.
A clinical assessment typically examines the pattern across situations, the feared consequences, duration, avoidance, distress, functional impairment, comorbid symptoms, medical factors, substance and medication effects, trauma history, and whether another diagnosis explains the presentation better.
Useful questions include:
• Which driving situations are feared: highways, traffic, bridges, tunnels, unfamiliar areas, long distances, being alone, or all driving?
• Is the fear mainly about escape, access to help, panic-like sensations, crashing, losing control of the vehicle, judgment by others, trauma reminders, or a medical event?
• Can the person drive when accompanied but not alone?
• Does the person avoid other agoraphobic situations outside driving?
• Have there been unexpected panic attacks outside feared driving contexts?
• Did the problem begin after a crash, fainting episode, vestibular illness, medication change, or other medical event?
• Is the person legally licensed and practically competent to drive?
• Does any current medication or medical condition impair safe driving?
The Mobility Inventory for Agoraphobia can help quantify avoidance patterns, including avoidance when alone versus accompanied. Research supports its reliability and aspects of convergent and discriminant validity, but a questionnaire score is not equivalent to a formal diagnosis (Chambless et al., 2011).
The American Psychiatric Association also provides a Severity Measure for Agoraphobia for symptom monitoring after a diagnosis or clinically significant symptoms have been identified; its own instructions place interpretation within clinical judgment and follow-up assessment (APA). Severity measurement, screening, clinical assessment, and diagnosis are different tasks.
Exposure-based treatment for agoraphobia and driving
Exposure is a central component of cognitive behavioral treatment for agoraphobia. The basic therapeutic idea is to approach feared situations in a planned way so that the person can learn something new rather than repeatedly escaping or avoiding.
The evidence base needs to be described precisely. Much of the high-quality trial literature historically studied panic disorder with agoraphobia rather than a clean sample of agoraphobia without panic disorder. A large network meta-analysis of 136 randomized trials of psychotherapy for panic disorder with or without agoraphobia found CBT among the interventions with the strongest evidence; after high-risk-of-bias trials were removed, CBT remained more efficacious than treatment as usual (Papola et al., 2022). NICE likewise recommends CBT for panic disorder and specifically discusses panic disorder with or without agoraphobia (NICE CG113).
That literature supports exposure-based CBT as an established approach within the panic/agoraphobia evidence base, but it should not be presented as if every trial were conducted in people with standalone agoraphobia or specifically with driving-related agoraphobia.
Research focused more directly on agoraphobic exposure also supports its central role. A systematic review and meta-analysis found large improvements in dysfunctional cognitions and self-efficacy following exposure-based treatment for agoraphobia, while noting that stronger study designs are needed to establish causal mediation (Breuninger et al., 2019). A multicenter randomized trial of 369 people with panic disorder and agoraphobia found clinically meaningful effects from structured CBT with in-situ exposure and examined whether therapist-guided exposure added benefit over therapist-prescribed exposure (Gloster et al., 2011).
For a broader explanation of the treatment model, see Exposure Therapy for Agoraphobia.
What exposure is trying to teach
Exposure is often misunderstood as “stay in the situation until anxiety goes away.” Anxiety reduction can happen, but contemporary learning models do not require every practice to end with calm.
An influential inhibitory-learning framework emphasizes new learning, including expectancy violation, variability, practice across contexts, and reducing reliance on safety signals when appropriate (Craske et al., 2014).
In driving-related agoraphobia, the useful questions may therefore be:
• What did I predict would happen?
• What actually happened?
• If anxiety rose, was I able to continue functioning safely?
• Did the feared catastrophe occur?
• What did I learn about being on this road, at this distance, or without my usual reassurance?
• Can I repeat the learning in another context?
The goal is broader behavioral freedom and more accurate threat learning, not proof that every drive will feel comfortable.
What safe graded driving exposure can look like
Driving exposure must preserve traffic safety. It is not a challenge to “push through” regardless of impairment.
A treatment plan usually begins by identifying feared situations and arranging them by difficulty. The hierarchy is individualized because the same road can be easy for one person and extremely difficult for another.
An illustrative progression might include:
1. Sitting in a parked car while noticing anticipatory anxiety.
2. Riding as a passenger on a familiar route.
3. Driving a very short familiar route under ordinary safe conditions.
4. Repeating the same route until it becomes less restricted by escape planning.
5. Driving a slightly longer route.
6. Driving a familiar route without the usual companion, if the person is licensed, competent, medically fit, and safe to drive alone.
7. Practicing moderate traffic or a route with longer red lights.
8. Driving across a short bridge or through a short tunnel.
9. Entering a highway for one exit.
10. Extending highway distance or combining several previously feared conditions.
11. Varying time of day, route, distance, and destination so learning is not tied to one narrowly controlled situation.
This is an example of how graded practice can be organized, not an individualized treatment prescription. The hierarchy should not include situations that are objectively unsafe, illegal, beyond the person’s driving competence, or medically contraindicated.
Start with safety eligibility, not fear intensity
Before in-traffic exposure, the person should be able to operate the vehicle safely and legally. A clinician may need to coordinate with a physician, driving rehabilitation specialist, occupational therapist, or qualified driving instructor when medical symptoms, medication effects, disability, skill loss, or prolonged driving cessation create uncertainty.
A therapeutic goal never turns an impaired person into a safe driver by definition.
Make the task specific
“Drive more” is vague. “Enter the highway at Exit A, remain for one exit, and leave at Exit B under normal daytime conditions” produces clearer learning.
Repeat and vary
A single successful drive can become another special case: “I only managed because the traffic was light.” Repetition and variation help test whether learning generalizes across routes, traffic levels, distances, and internal sensations.
Track predictions, not only anxiety ratings
A person may rate anxiety as 7 out of 10 and still discover that they stayed in lane, followed traffic rules, and reached the destination without the predicted catastrophe. That can be therapeutically important even when anxiety did not fall to 0.
Increase difficulty without making the road unsafe
Difficulty can be increased by route length, distance from home, being alone, traffic density, or reduced reassurance. It should not be increased by speeding, sleep deprivation, unsafe weather, medication impairment, distraction, or violating traffic laws.
Driving-specific CBT evidence: promising, but still limited
Direct research on treatment specifically for driving fear is much smaller than the general CBT and exposure literature.
A pilot randomized controlled trial of 34 participants found that an 18-session CBT protocol for driving fear outperformed a wait-list condition on driving-fear measures and reported large effects, but the sample was small and the study was explicitly a pilot (Fischer et al., 2021). The protocol addressed different driving-related fear patterns rather than proving that one method is established specifically for agoraphobic driving fear.
This is a useful distinction in evidence status:
• Established evidence: CBT and exposure-based methods are well supported across anxiety disorders and within the panic/agoraphobia literature.
• Strongly plausible clinical application: adapting graded in-vivo exposure to driving situations when driving is part of agoraphobic avoidance.
• More limited direct evidence: randomized treatment research specifically on “agoraphobia and driving” as a narrowly defined subgroup.
• Preliminary evidence: specialized driving-fear protocols and virtual-reality approaches with small samples.
That hierarchy is more accurate than saying “driving exposure is proven” without specifying the population and intervention studied.
Therapist-guided versus self-directed exposure
Some people can carry out portions of exposure practice independently after assessment and planning. Others benefit from therapist guidance, especially when fear is severe, avoidance has become extensive, or the person has difficulty distinguishing anxiety-driven escape from genuine road-safety concerns.
In the 2011 multicenter trial of panic disorder with agoraphobia, both treatment variants used structured CBT and in-situ exposure, but one condition included therapist-accompanied exposure outside the therapy room while the other relied on therapist-prescribed practice (Gloster et al., 2011). The study supports the clinical importance of how exposure is implemented, although it was not a trial specifically about driving.
A therapist accompanying a driving exposure also does not replace a driving instructor. Psychotherapy addresses fear learning and avoidance; driving instruction addresses vehicle operation and road skill. Some cases need both.
What to do with a companion
A companion can be useful during early practice, but the function matters.
If the person believes, “I can drive only because this person can rescue me,” the companion may become part of the feared situation’s safety structure. Treatment may then gradually vary the companion’s role or eventually include driving alone when that is appropriate and safe.
On the other hand, abruptly removing a companion is not automatically superior. The safety-behavior literature does not support a rigid rule that all safety-seeking behaviors must be eliminated immediately (Meulders et al., 2016). A graded plan can use support strategically while still creating opportunities for new learning.
The clinically useful question is: “Does this support make safe practice possible, or does it become evidence in the person’s mind that the situation is survivable only with rescue?”
What if panic starts while driving?
Panic symptoms can be intensely distracting. The first priority while driving is road safety, not completing an exposure exercise.
If symptoms rise but the driver remains able to operate the vehicle safely, the person can keep attention on the driving task rather than turning inward to monitor every bodily sensation. If the driver’s ability to control the vehicle is compromised, the appropriate response is to follow traffic rules and move to a safe place to stop when that can be done safely.
A panic attack can involve palpitations, shortness of breath, dizziness, trembling, chest discomfort, derealization, and fear of losing control. Those symptoms overlap with medical conditions. A first severe episode, actual fainting, new neurological signs, unusual chest pain, persistent severe shortness of breath, or other concerning symptoms should not be diagnosed online as anxiety by symptom resemblance alone.
The dedicated article Panic Attacks While Driving covers panic-specific safety and differential diagnosis in more detail.
Agoraphobia can occur without panic disorder
One of the most persistent misconceptions is that agoraphobia must be caused by panic attacks.
Panic attacks can be part of the picture, but agoraphobia and panic disorder are separate diagnoses. The driving fear may be organized around escape difficulty, fear of incapacitation, gastrointestinal urgency, dizziness, embarrassment, or another feared event without the person meeting criteria for panic disorder.
That distinction affects treatment planning. Interoceptive exposure—deliberately practicing feared bodily sensations—is highly relevant when catastrophic interpretations of bodily sensations are central, especially in panic disorder. A person whose main problem is situational escape fear without panic-focused catastrophic beliefs may need a different emphasis, such as in-vivo situational exposure and work on avoidance, self-efficacy, and threat predictions.
Medication and driving exposure
Medication can be part of treatment for some anxiety disorders, but medication decisions and driving-safety decisions need to be separated carefully.
NICE recommends CBT for panic disorder and discusses antidepressants as an option for some people with moderate to severe or long-standing panic disorder, while advising against benzodiazepines for panic disorder because of poorer long-term outcomes (NICE CG113). Those recommendations are about panic disorder, including cases with agoraphobia; they should not be generalized into a universal medication rule for every person with standalone agoraphobia.
For driving specifically, the immediate issue is impairment. The FDA notes that benzodiazepines, some antidepressants, sleep medications, antihistamines, opioids, and other medicines can impair driving in some people (FDA). NHTSA similarly emphasizes that both prescription and over-the-counter drugs can affect judgment, coordination, alertness, and reaction time (NHTSA).
A medication should therefore not be used as a “bravery tool” for a driving exposure when it makes the person unsafe to drive. People taking prescribed medication should follow their clinician’s and product-label instructions and should not stop or change medication solely to conduct exposure practice.
Virtual reality and driving simulators
Virtual reality can reproduce highways, traffic, tunnels, bridges, or other driving situations without immediately entering real traffic. That makes it intuitively attractive when in-vivo driving feels inaccessible.
The evidence is promising but limited.
A 2023 systematic review identified 14 studies of VR-based psychological treatment for driving phobia. The studies were generally small and methodologically weak, with diagnostic ambiguity and insufficient consistency for quantitative pooling. The review concluded that VR approaches may be feasible and acceptable but that higher-quality trials are needed before strong treatment recommendations can be made (Elphinston et al., 2023).
A small 2020 pilot study treated 14 people with driving phobia using tailored virtual-reality exposure followed by a real-traffic behavioral test. The results were encouraging, but the authors explicitly called for randomized controlled trials (Kaussner et al., 2020).
Research in agoraphobia also does not establish VR as superior to real-world exposure. In a randomized trial of 55 people with panic disorder and agoraphobia, CBT plus VR exposure and CBT plus in-vivo exposure were both better than a wait-list condition on most outcomes, while in-vivo exposure was superior on one panic-severity measure; the authors did not recommend VR as an added-value replacement on the evidence available at that time (Meyerbröker et al., 2013).
VR may therefore be an adjunct or bridge, especially when carefully integrated into a broader treatment plan. It should not be presented as a proven substitute for real-world driving practice when the functional goal is to drive safely in actual traffic.
Why “forcing yourself” can be a bad treatment model
Exposure is planned learning, not a dare.
Driving while overwhelmed, medically unwell, impaired by medication, severely sleep-deprived, or unable to maintain attention and vehicle control is not therapeutic courage. It is unsafe driving.
Even when the person is medically and practically safe to drive, jumping immediately to the most feared situation may produce an experience dominated by escape, white-knuckling, or a sense of failure. Some treatment protocols use intensive exposure successfully, but intensity should be clinically chosen rather than equated with effectiveness.
Graded exposure allows the task to be difficult enough to generate useful learning while remaining behaviorally manageable and safe.
How recovery is measured
Recovery from driving-related agoraphobia is better measured by flexibility and functioning than by complete absence of anxiety.
Useful markers can include:
• a larger geographic driving range;
• the ability to use routes that were previously avoided;
• less dependence on a companion;
• less route selection based solely on escape opportunities;
• greater tolerance of traffic, bridges, tunnels, or distance when those situations are relevant;
• reduced disruption to work, health care, family responsibilities, and social life;
• less time spent planning around anxiety;
• greater confidence in handling anxiety without abandoning the driving task;
• the ability to experience bodily sensations without immediately interpreting them as proof that escape is necessary.
The Mobility Inventory’s separate alone-versus-accompanied ratings illustrate why “I drove” is not always enough to describe functional change (Chambless et al., 1985). The conditions under which the person can move through the world matter.
Progress can also be uneven. Someone may regain local driving before highways, or daytime driving before night driving. A temporary return of anxiety does not erase learning. Exposure models explicitly recognize that fear can return in some contexts, which is one reason practice across varied contexts is useful (Craske et al., 2014).
When professional assessment is especially useful
Professional assessment becomes particularly important when:
• driving avoidance substantially restricts work, health care, caregiving, education, or social life;
• the person can drive only with a companion or within a very small area;
• panic attacks are recurrent or unexpected;
• the fear followed a serious collision or other trauma;
• dizziness, fainting, loss of consciousness, seizure-like symptoms, visual disturbance, or other medical symptoms are present;
• medication may be impairing alertness or coordination;
• the person has not driven for a long period and driving skill itself may need reassessment;
• self-directed exposure repeatedly ends in abrupt escape or increasing restriction;
• depression, substance use, or other mental health problems are complicating treatment.
A clinician can help determine whether the central problem is agoraphobia, panic disorder, specific phobia, trauma-related symptoms, another anxiety condition, a medical issue, or a combination.
For a broad overview of anxiety disorders and their diagnostic boundaries, see Anxiety Disorders.
Practical principles for a driving exposure plan
A useful plan usually has several parts.
Define the feared prediction
Instead of “highways are scary,” identify the expected event: “I will panic and lose control,” “I will be trapped and unable to leave,” “I will faint before the next exit,” or “I will not cope if I cannot stop.”
Different predictions require different assessment. A belief about fainting may need medical evaluation; a belief about panic may call for panic-focused work; a belief about escape may call for situational exposure.
Define the actual task
Specify route, distance, time, traffic conditions, whether a companion is present, and the intended endpoint. That makes repetition and comparison possible.
Separate therapeutic discomfort from unsafe impairment
Anxiety is uncomfortable. Impaired consciousness, unsafe sedation, inability to see clearly, uncontrolled seizure activity, or loss of vehicle control are safety problems. They belong in different categories.
Decide what counts as completion
Completion should usually be behavioral: entering the route, staying for the planned segment, following road rules, and arriving or exiting safely. “I felt calm” is not a necessary criterion.
Review what was learned
Afterward, compare prediction with outcome. Notice both feared outcomes that did not happen and coping that occurred when anxiety did happen.
Repeat enough to test generalization
If the person succeeds only on one exact road at one exact time with one exact companion, the learning may remain narrow. Variation can be introduced gradually.
Common mistakes in self-directed driving exposure
Several patterns can make practice less useful or less safe.
Turning the exercise into endurance
White-knuckling through a drive while repeating “I must not feel anxious” can make anxiety itself the enemy. The learning target is the ability to function safely and tolerate uncertainty, not emotional perfection.
Practicing only when anxiety is unusually low
Waiting for a “good day” can teach that driving is possible only under special internal conditions.
Repeating only one safe route
Familiarity can help initially, but recovery usually requires generalization beyond one carefully controlled path.
Treating every coping strategy as forbidden
Some supports are ordinary safety measures. Others may be temporary scaffolding. The function of a behavior matters more than a blanket rule.
Using sedating medication to make an exposure possible
If a medication impairs alertness, coordination, or reaction time, driving exposure should not proceed. Medication safety takes priority.
Ignoring skill deterioration
Someone who has avoided driving for years may need practical driving instruction in addition to psychotherapy. Fear treatment cannot substitute for road competence.
Assuming every physical symptom is panic
Chest pain, severe breathlessness, fainting, neurological symptoms, visual changes, and other acute symptoms can have medical causes. Online pattern matching is not a safe differential diagnosis.
Frequently asked questions
Can agoraphobia make driving difficult?
Yes. Driving can become an agoraphobic situation when the person fears being unable to escape or obtain help if intense anxiety or other feared symptoms occur. NIMH specifically lists traveling in a car among situations that may be avoided in agoraphobia (NIMH).
Is fear of driving always agoraphobia?
No. Fear of driving may occur in agoraphobia, specific phobia, panic disorder, trauma-related conditions, social anxiety, or in response to medical symptoms or medication effects. The feared consequence and the broader pattern of avoidance matter.
Why are highways often harder than local roads?
Highways can reduce perceived escape options because exits are spaced apart and stopping is restricted. For someone with agoraphobia, that can amplify fears of being trapped or unable to get help. Older driving-fear research also found freeways, bridges, and tunnels commonly feared, although the study used older diagnostic categories (Ehlers et al., 1994).
Why can I drive with someone but not alone?
A companion may provide reassurance, perceived help, or the belief that someone else can take over. Clinical tools for agoraphobia often measure avoidance separately when alone and accompanied because this difference can be meaningful (Chambless et al., 1985). It still does not diagnose agoraphobia by itself.
Can agoraphobia happen without panic attacks?
Yes. Agoraphobia and panic disorder are separate diagnoses. Panic attacks can occur in agoraphobia without a co-occurring panic disorder, and panic attacks are not required to explain every agoraphobic fear (WHO ICD-11 CDDR).
Can exposure therapy help with driving-related agoraphobia?
Exposure is a central component of evidence-based CBT for agoraphobia and panic/agoraphobia presentations. Applying exposure specifically to driving is clinically plausible and supported by broader exposure evidence, while direct randomized evidence for narrowly defined driving-related agoraphobia remains limited. A small pilot randomized trial of CBT for driving fear was promising, but it had only 34 participants (Fischer et al., 2021).
Should I force myself to keep driving through a panic attack?
The priority is safe vehicle operation. If anxiety rises while you remain able to drive safely, therapeutic work may involve staying engaged with the driving task rather than immediately escaping. If symptoms impair vehicle control, attention, consciousness, or vision, move to a safe place according to traffic rules when possible and seek appropriate medical help. Exposure never requires unsafe driving.
Is virtual reality effective for fear of driving?
VR treatment is promising, but the direct evidence for driving phobia remains limited and methodologically weak. A 2023 systematic review found possible feasibility and acceptability but concluded that stronger trials are needed before firm recommendations can be made (Elphinston et al., 2023).
Can medication help me drive during exposure?
Medication may be part of treatment for an anxiety disorder, but some medications can impair driving. The FDA specifically warns that certain anxiety medications, sleep medicines, some antidepressants, and other drugs can cause effects that make driving unsafe (FDA). Medication should not be added, stopped, or changed simply to conduct a driving exposure without clinical guidance.
How long does recovery take?
There is no universal timetable. Severity, duration, comorbidity, driving skill, treatment access, medical factors, and the range of avoided situations all matter. Evidence-based CBT protocols can be time-limited, but regaining a broad driving range may require repeated practice across multiple contexts. Functional improvement is more informative than a promise that anxiety will disappear by a particular date.
Related Articles
References
American Psychiatric Association. (2022). Severity Measure for Agoraphobia—Adult. DSM-5-TR Online Assessment Measures.
Breuninger, C., Tuschen-Caffier, B., & Svaldi, J. (2019). Dysfunctional cognition and self-efficacy as mediators of symptom change in exposure therapy for agoraphobia—Systematic review and meta-analysis. Behaviour Research and Therapy, 120, 103443. PubMed. https://doi.org/10.1016/j.brat.2019.103443
Chambless, D. L., Caputo, G. C., Jasin, S. E., Gracely, E. J., & Williams, C. (1985). The Mobility Inventory for Agoraphobia. Behaviour Research and Therapy, 23(1), 35–44. PubMed. https://doi.org/10.1016/0005-7967(85)90140-8
Chambless, D. L., Sharpless, B. A., Rodriguez, D., McCarthy, K. S., Milrod, B. L., Khalsa, S.-R., & Barber, J. P. (2011). Psychometric properties of the Mobility Inventory for Agoraphobia: Convergent, discriminant, and criterion-related validity. Behavior Therapy, 42(4), 689–699. PubMed. https://doi.org/10.1016/j.beth.2011.03.001
Craske, M. G., Treanor, M., Conway, C. C., Zbozinek, T., & Vervliet, B. (2014). Maximizing exposure therapy: An inhibitory learning approach. Behaviour Research and Therapy, 58, 10–23. PubMed. https://doi.org/10.1016/j.brat.2014.04.006
Ehlers, A., Hofmann, S. G., Herda, C. A., & Roth, W. T. (1994). Clinical characteristics of driving phobia. Journal of Anxiety Disorders, 8(4), 323–339. Journal. https://doi.org/10.1016/0887-6185(94)00021-2
Elphinston, R. A., Vaezipour, A., Fowler, J. A., Russell, T. G., & Sterling, M. (2023). Psychological therapy using virtual reality for treatment of driving phobia: A systematic review. Disability and Rehabilitation, 45(10), 1582–1594. PubMed. https://doi.org/10.1080/09638288.2022.2069293
Fischer, C., Heider, J., Taylor, J. E., & Schröder, A. (2021). Cognitive behavior therapy for driving fear: A pilot randomized controlled trial. Transportation Research Part F: Traffic Psychology and Behaviour, 83, 118–129. https://doi.org/10.1016/j.trf.2021.10.005
Gloster, A. T., Wittchen, H.-U., Einsle, F., Lang, T., Helbig-Lang, S., Fydrich, T., Fehm, L., Hamm, A. O., Richter, J., Alpers, G. W., Gerlach, A. L., Ströhle, A., Kircher, T., Deckert, J., Zwanzger, P., Höfler, M., & Arolt, V. (2011). Psychological treatment for panic disorder with agoraphobia: A randomized controlled trial to examine the role of therapist-guided exposure in situ in CBT. Journal of Consulting and Clinical Psychology, 79(3), 406–420. PubMed. https://doi.org/10.1037/a0023584
Kaussner, Y., Kuraszkiewicz, A. M., Schoch, S., Markel, P., Hoffmann, S., Baur-Streubel, R., Kenntner-Mabiala, R., & Pauli, P. (2020). Treating patients with driving phobia by virtual reality exposure therapy—A pilot study. PLOS ONE, 15(1), e0226937. https://doi.org/10.1371/journal.pone.0226937
Meulders, A., Van Daele, T., Volders, S., & Vlaeyen, J. W. S. (2016). The use of safety-seeking behavior in exposure-based treatments for fear and anxiety: Benefit or burden? A meta-analytic review. Clinical Psychology Review, 45, 144–156. https://doi.org/10.1016/j.cpr.2016.02.002
Meyerbröker, K., Morina, N., Kerkhof, G. A., & Emmelkamp, P. M. G. (2013). Virtual reality exposure therapy does not provide any additional value in agoraphobic patients: A randomized controlled trial. Psychotherapy and Psychosomatics, 82(3), 170–176. PubMed. https://doi.org/10.1159/000342715
National Highway Traffic Safety Administration. Prescription and Over-the-Counter Medicines. NHTSA.
National Institute of Mental Health. Agoraphobia. NIMH.
National Institute for Health and Care Excellence. (2011, updated 2020). Generalised anxiety disorder and panic disorder in adults: management (CG113). Recommendations.
Papola, D., Ostuzzi, G., Tedeschi, F., Gastaldon, C., Purgato, M., Del Giovane, C., Pompoli, A., Pauley, D., Karyotaki, E., Sijbrandij, M., Furukawa, T. A., Cuijpers, P., & Barbui, C. (2022). Comparative efficacy and acceptability of psychotherapies for panic disorder with or without agoraphobia: Systematic review and network meta-analysis of randomised controlled trials. The British Journal of Psychiatry, 221(3), 507–519. PubMed. https://doi.org/10.1192/bjp.2021.148
U.S. Food and Drug Administration. Some Medicines and Driving Don’t Mix. FDA.
Uwents, M.-H., Jorissen, C., Van Ombergen, A., Dobbels, B., van de Berg, R., Janssens de Varebeke, S., Lammers, M., Ross, V., Vanderveken, O., Brijs, T., & Van Rompaey, V. (2022). Driving ability in patients with dizziness: A systematic review. European Archives of Oto-Rhino-Laryngology, 279(4), 1813–1829. PubMed. https://doi.org/10.1007/s00405-021-06881-8
World Health Organization. (2024). Clinical descriptions and diagnostic requirements for ICD-11 mental, behavioural and neurodevelopmental disorders. WHO.
World Health Organization. (2026). Anxiety disorders. WHO.